Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2016

View Archived Issues

PDS Biotechnology's PDS-0101 shows promise in phase I/IIa study

Vertex advances plans for next-generation correctors for cystic fibrosis

Bayer compares BAY-1003803 formulations in psoriasis plaque test

Theravance Biopharma reports data from phase I MAD study of TD-0714

Lexicon Pharmaceuticals reports positive results for phase II trial of sotagliflozin

Moleculin Biotech announces positive data for WP-1122 toxicity testing in mice

Debiopharm International completes phase II trial of Debio-1450

Sanofi, WRAIR and Fiocruz agree principles of collaboration for Zika vaccine development

Minerva Neurosciences reports data for phase IIb trial of MIN-101

[225Ac]PSMA-617 as promising new PSMA-targeted radiation therapy for mCRPC

Entasis Therapeutics starts phase I trial of ETX-2514

Novel radioligands show promise as imaging and therapeutic agents for GRPR-expressing tumors

ApeX Therapeutics changes corporate name to Apexian Pharmaceuticals

Changzhou Longthera Pharmaceuticals patents CDK/cyclin D1 inhibitors

Hangzhou Innogate Pharma discloses IDO-1 and/or TDO inhibitors

Selecta Biosciences doses first patient in phase II trial of SEL-212

Eli Lilly describes GOAT inhibitors

Merck & Co. develops FXIa and/or plasma kallikrein inhibitors

Allergan completes tender offer for Vitae Pharmaceuticals

Ultragenyx Pharmaceutical starts phase III trial of burosumab

Silvergate announces U.S. availability of Qbrelis

New BRAC2 mutation characterized in a family with male and female breast cancer

Apitope enrolls first patient in phase I trial of ATX-GD-59

Boehringer Ingelheim discloses topline data from phase III trial of BI-695501

Myriad RBM to work with Sanofi to perform biomarker analysis of blood samples from ELIXA trial

Serodus, Lam Therapeutics and Actelion receive FDA orphan designations for treatments in PAH

MYH3 gene variants may cause congenital scoliosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...